poisar

Stocks · News reference

Dassault Systemes Sees Q3 Adj EPS $0.35-$0.37 vs $0.35 Est; Sees Sales $1.766B-$1.814B vs $1.780B Est

BenzingaJul 23, 2026, 7:57 AMBenzinga Newsdesk

Dassault Systemes (OTC:DASTY) is looking for Q3 Adj EPS of $0.35-$0.37 vs $0.35 analyst estimate. sees sales of $1.766 billion-$1.814 billion vs $1.780 billion analyst estimate.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Jul 23, 2026, 7:57 AM
Checked
Jul 23, 2026, 7:57 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncJul 23, 2026, 4:57 AMNa

    Dassault Systèmes to acquire ArisGlobal, creating a unified AI intelligence platform for the Life Sciences industry connecting molecule, patient and real-world outcomes

    Dassault Systèmes announced the acquisition of ArisGlobal for approximately $1.8 billion in cash plus up to $200 million in milestone-based consideration. The deal combines ArisGlobal's AI-native compliance platform serving 200+ customers with Dassault Systèmes' domain expertise in drug discovery and manufacturing, creating a unified intelligence platform for the Life Sciences industry. The transaction is expected to close in H2 2026 and be accretive to revenue growth and EPS in Year 1.

    Read original at globenewswire-inc
  2. Globenewswire IncJul 23, 2026, 4:57 AMDassault Systèmes

    Dassault Systèmes acquiert ArisGlobal pour créer une plateforme d’IA unifiée pour les Sciences de la vie, reliant molécule, patient et résultats du monde réel

    Dassault Systèmes announced the acquisition of ArisGlobal for approximately $1.8 billion in cash, plus up to $200 million in performance-based earnouts. The deal combines Dassault's expertise in R&D, clinical development, and manufacturing with ArisGlobal's AI-native compliance platform serving over 200 life sciences clients. The acquisition is expected to be accretive to earnings per share in the first year and create a unified AI intelligence platform for the life sciences industry.

    Read original at globenewswire-inc